Skip to main content

AETC National Coordinating Resource Center
Resources for Clinicians
AETC Directory
Download App

Breadcrumb

Home

New Topics in HIV Meds Updates: Dolutegravir/Lamivudine Combination Approved; Long-Acting Injectable ART; PrEP: TDF/FTC vs TAF/FTC in MSM

Susa Coffey, MD; 4/24/2019.

Log in to post comments

About
Contact Us
Log in

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award (grant number U1OHA28686) totaling $1,700,000 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.